bioRxivCancer Biology
MITF reprograms the extracellular matrix and focal adhesion in melanoma
R. Dilshat, V. Fock, C. Kenny, I. Gerritsen, R. M. J. Lasseur, O. Eichhoff, J. Travnickova, P. Cerny, K. Moller, S. Sigurbjornsdottir, K. Kirty, B. O. Einarsdottir, P. F. Cheng, M. Levesque, R. Cornell, E. E. Patton, L. Larue, M. de Tayrac, E. Magnusdottir, M. H. Ogmundsdottir, E. Steingrimsson
Abstract
The microphthalmia associated transcription factor (MITF) is a critical regulator of melanocyte development and differentiation. It also plays an important role in melanoma where it has been described as a molecular rheostat that, depending on activity levels, allows reversible switching between different cellular states. Here we show that MITF directly represses the expression of genes associated with the extracellular matrix (ECM) and focal adhesion pathways in human melanoma cells as well as of regulators of epithelial to mesenchymal transition (EMT) such as CDH2, thus affecting cell morphology and cell-matrix interactions. Importantly, we show that these effects of MITF are reversible, as expected from the rheostat model. The number of focal adhesion points increased upon MITF knockdown, a feature observed in drug resistant melanomas. Cells lacking MITF are similar to the cells of minimal residual disease observed in both human and zebrafish melanomas. Our results suggest that MITF plays a critical role as a repressor of gene expression and is actively involved in shaping the microenvironment of melanoma cells in a cell-autonomous manner.
- organism: human
- organism: zebrafish
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Melanocyte differentiation and mechanosensation are differentially modulated by distinct extracellular matrix proteins
Carole Luthold, Marie Didion, … Sandra Iden·EMBO ReportsPeer-reviewed·Sep 19, 2025
- Antagonistic Roles for MITF and TFE3 in Melanoma Plasticity
Jeremy Chang, Katelyn R. Campbell-Hanson, … Colin Kenny·Cell ReportsPeer-reviewed·Mar 26, 2025
- The small MAF transcription factor MAFG co-opts MITF to promote melanoma progression
Olga Vera, Michael Martinez, … Florian A. Karreth·Nature CommunicationsPeer-reviewed·May 21, 2026
- Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma.
Diogo Dias, Erica Aparecida de Oliveira, … Colin R. Goding·Cell ReportsPeer-reviewed·Nov 22, 2025
- MITF regulates IDH1 and NNT and drives a transcriptional program protecting cutaneous melanoma from reactive oxygen species
E. Roider, A. I. T. Lakatos, … D. E. Fisher·bioRxiv·Nov 10, 2023
- Melanoma cells suppress mast cell growth via a melanin-dependent mechanism
Fábio Rabelo Melo, Lea Nyman, … Gunnar Pejler·bioRxiv·Feb 3, 2025